vs
INTEST CORP（INTT）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
INTEST CORP的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$32.8M vs $19.6M），INTEST CORP净利率更高（3.8% vs -177.4%，领先181.2%），INTEST CORP同比增速更快（-10.3% vs -11.5%），INTEST CORP自由现金流更多（$-1.6M vs $-23.1M），过去两年INTEST CORP的营收复合增速更高（4.9% vs -12.2%）
INTEST CORP是面向全球半导体产业的专业测试设备供应商，主营研发、生产及销售热管理系统、测试接口硬件、晶圆处理工具等产品，客户覆盖晶圆制造厂、芯片设计企业及汽车、工业电子等下游领域。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
INTT vs LAB — 直观对比
营收规模更大
INTT
是对方的1.7倍
$19.6M
营收增速更快
INTT
高出1.1%
-11.5%
净利率更高
INTT
高出181.2%
-177.4%
自由现金流更多
INTT
多$21.5M
$-23.1M
两年增速更快
INTT
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.8M | $19.6M |
| 净利润 | $1.2M | $-34.7M |
| 毛利率 | 45.4% | 48.5% |
| 营业利润率 | 3.9% | -168.5% |
| 净利率 | 3.8% | -177.4% |
| 营收同比 | -10.3% | -11.5% |
| 净利润同比 | -17.4% | -28.8% |
| 每股收益（稀释后） | $0.10 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INTTLAB
| Q4 25 | $32.8M | — | ||
| Q3 25 | $26.2M | $19.6M | ||
| Q2 25 | $28.1M | $21.8M | ||
| Q1 25 | $26.6M | $40.8M | ||
| Q4 24 | $36.6M | — | ||
| Q3 24 | $30.3M | $22.1M | ||
| Q2 24 | $34.0M | $22.5M | ||
| Q1 24 | $29.8M | $45.5M |
净利润INTTLAB
| Q4 25 | $1.2M | — | ||
| Q3 25 | $-938.0K | $-34.7M | ||
| Q2 25 | $-503.0K | $-33.5M | ||
| Q1 25 | $-2.3M | $-26.0M | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $495.0K | $-26.9M | ||
| Q2 24 | $230.0K | $-45.7M | ||
| Q1 24 | $662.0K | $-32.2M |
毛利率INTTLAB
| Q4 25 | 45.4% | — | ||
| Q3 25 | 41.9% | 48.5% | ||
| Q2 25 | 42.6% | 48.8% | ||
| Q1 25 | 41.5% | 48.4% | ||
| Q4 24 | 39.7% | — | ||
| Q3 24 | 46.3% | 54.9% | ||
| Q2 24 | 40.6% | 46.1% | ||
| Q1 24 | 43.8% | 53.1% |
营业利润率INTTLAB
| Q4 25 | 3.9% | — | ||
| Q3 25 | -4.5% | -168.5% | ||
| Q2 25 | -3.3% | -118.1% | ||
| Q1 25 | -10.8% | -80.8% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 1.6% | -120.9% | ||
| Q2 24 | 1.0% | -134.5% | ||
| Q1 24 | 1.6% | -132.2% |
净利率INTTLAB
| Q4 25 | 3.8% | — | ||
| Q3 25 | -3.6% | -177.4% | ||
| Q2 25 | -1.8% | -153.7% | ||
| Q1 25 | -8.7% | -63.8% | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 1.6% | -122.0% | ||
| Q2 24 | 0.7% | -203.3% | ||
| Q1 24 | 2.2% | -70.6% |
每股收益（稀释后）INTTLAB
| Q4 25 | $0.10 | — | ||
| Q3 25 | $-0.08 | $-0.09 | ||
| Q2 25 | $-0.04 | $-0.09 | ||
| Q1 25 | $-0.19 | $-0.07 | ||
| Q4 24 | $0.13 | — | ||
| Q3 24 | $0.04 | $-0.07 | ||
| Q2 24 | $0.02 | $-0.12 | ||
| Q1 24 | $0.05 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.2M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $103.6M | $399.7M |
| 总资产 | $151.3M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INTTLAB
| Q4 25 | $14.2M | — | ||
| Q3 25 | $16.2M | $129.4M | ||
| Q2 25 | $19.2M | $158.6M | ||
| Q1 25 | $22.0M | $150.9M | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $18.0M | $210.6M | ||
| Q2 24 | $20.4M | $269.8M | ||
| Q1 24 | $27.3M | $287.1M |
总债务INTTLAB
| Q4 25 | — | — | ||
| Q3 25 | $4.9M | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $7.9M | — | ||
| Q3 24 | $9.0M | $55.2M | ||
| Q2 24 | $10.0M | $55.1M | ||
| Q1 24 | $11.0M | $55.0M |
股东权益INTTLAB
| Q4 25 | $103.6M | — | ||
| Q3 25 | $101.9M | $399.7M | ||
| Q2 25 | $102.6M | $424.5M | ||
| Q1 25 | $99.4M | $454.6M | ||
| Q4 24 | $99.8M | — | ||
| Q3 24 | $100.4M | $489.3M | ||
| Q2 24 | $99.5M | $510.3M | ||
| Q1 24 | $99.3M | $577.3M |
总资产INTTLAB
| Q4 25 | $151.3M | — | ||
| Q3 25 | $148.3M | $539.6M | ||
| Q2 25 | $149.7M | $557.0M | ||
| Q1 25 | $148.0M | $579.6M | ||
| Q4 24 | $152.3M | — | ||
| Q3 24 | $158.4M | $681.5M | ||
| Q2 24 | $160.6M | $708.7M | ||
| Q1 24 | $159.5M | $777.7M |
负债/权益比INTTLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.09× | 0.11× | ||
| Q2 24 | 0.10× | 0.11× | ||
| Q1 24 | 0.11× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | -4.7% | -118.1% |
| 资本支出强度资本支出/营收 | 1.6% | 4.5% |
| 现金转化率经营现金流/净利润 | -0.82× | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流INTTLAB
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $3.5M | $-22.2M | ||
| Q2 25 | $-688.0K | $-20.7M | ||
| Q1 25 | $5.5M | $-30.3M | ||
| Q4 24 | $2.6M | — | ||
| Q3 24 | $4.2M | $-27.9M | ||
| Q2 24 | $-5.1M | $-39.0M | ||
| Q1 24 | $2.1M | $-62.5M |
自由现金流INTTLAB
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $3.1M | $-23.1M | ||
| Q2 25 | $-1.1M | $-22.6M | ||
| Q1 25 | $5.3M | $-35.3M | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.7M | $-30.1M | ||
| Q2 24 | $-5.4M | $-41.0M | ||
| Q1 24 | $1.7M | $-63.3M |
自由现金流率INTTLAB
| Q4 25 | -4.7% | — | ||
| Q3 25 | 11.8% | -118.1% | ||
| Q2 25 | -4.1% | -103.6% | ||
| Q1 25 | 19.9% | -86.6% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 12.4% | -136.4% | ||
| Q2 24 | -15.9% | -182.2% | ||
| Q1 24 | 5.8% | -138.9% |
资本支出强度INTTLAB
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.6% | 4.5% | ||
| Q2 25 | 1.6% | 8.7% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 1.7% | 10.2% | ||
| Q2 24 | 0.9% | 8.6% | ||
| Q1 24 | 1.1% | 1.7% |
现金转化率INTTLAB
| Q4 25 | -0.82× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | 8.58× | — | ||
| Q2 24 | -22.13× | — | ||
| Q1 24 | 3.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTT
| Environmental Technologies | $8.3M | 25% |
| Semiconductor Market | $6.9M | 21% |
| Thermal Testing Products | $6.4M | 19% |
| Service And Other Products | $4.8M | 15% |
| Oem Integrators And Distributor | $3.5M | 11% |
| Semiconductor Production Test Products | $3.0M | 9% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
